Two Voices Behind PIHKAL and TIHKAL
The collaborative work of Alexander “Sasha” Shulgin and Ann Shulgin is often reduced to the image of the chemist who synthesized and bioassayed hundreds of psychoactive compounds. Yet it is worth remembering that PIHKAL and TIHKAL are books written in two distinct voices: alongside Sasha’s chemical entries and bioassay protocols are the first-person narratives of Ann, a lay therapist and keen observer of the inner world. It is precisely in this subjective half where the Shulgin project becomes most compelling from a psychonautical perspective, treating consciousness as a territory to be explored rather than a mere pharmacological side effect.
Chapter 12 of TIHKAL is a prime example. In it, Ann discusses no drug at all: she describes an experience that arose spontaneously during sleep, and the long process of finding the courage to write about it.
Lucid Dreaming: Waking Up Inside the Dream
A lucid dream is one where the sleeper becomes aware that they are dreaming. The observing ego remains intact, and with practice, one can subtly steer the narrative: if a scenario turns distressing, the realization that “this is a dream” allows the dreamer to redirect the scene or wake up. This is not esoteric lore; lucid dreaming is well-documented in sleep science and correlates with distinct neural activity patterns during REM sleep. For anyone fascinated by altered states of consciousness, lucid dreaming provides a drug-free laboratory—a profound shift in experience generated entirely from within.
Ann Shulgin wrote that she came to lucid dreaming later in life, well into adulthood. Eventually, these dreams began carrying an unexpected dimension: an intense sexual charge located not in the genitals, but in a somatic region just above the pubic bone, where a full bladder can be felt under light pressure. In her account, when this energy peaked, it released as an orgasm she described as far more powerful than any other, shaking her entire body and leaving her breathless.
The “Secret Place”
What gives the story depth is not just the phenomenon itself, but the hesitation surrounding it. Ann explains that for years she had shared it only with Sasha, unsure whether anyone else had experienced anything like it and hesitant to ask for fear of making others uncomfortable. She eventually brought it up with an acquaintance from London who had embraced Tibetan Buddhism. According to him, this center above the pubic bone has a name in Buddhist tradition: the “Secret Place.”
He also confided that he had felt something identical while fully awake during an outdoor LSD trip: the same displaced desire, the same powerful culmination in that specific area of the body. Both viewed the sensation less as a purely sexual release and more as a profound inner affirmation—“you are alive, powerful forces dwell within you, life is worth living”—though neither claimed to possess a definitive explanation. What resonates most is that deeply human yearning to validate an unusual, solitary experience through someone else’s words.
It is wise to treat the story’s Buddhist framework cautiously. The “Secret Place” appears here as an informal colloquial label from a private conversation, not a verified doctrinal citation, and their spiritual interpretation was explicitly intuitive. It stands as an honest personal testimony, not clinical or theological proof.
2C-D: Shulgin’s “Pharmacological Tofu”
The second half of the chapter shifts focus to an actual molecule: 2C-D (2,5-dimethoxy-4-methylphenethylamine), a member of the “2C” family. While its initial synthesis is credited to an American research team, Shulgin extensively explored its effects in humans and cemented its place in psychonaut lore. In Germany, psychiatrist Hanscarl Leuner investigated its potential for psycholytic psychotherapy during the pre-prohibition wave of psychedelic research.
Shulgin’s moniker sums it up: “pharmacological tofu.” 2C-D offers little distinct flavor on its own; instead, it absorbs, extends, and softens whatever is taken alongside it, much like tofu soaks up the sauce in which it is cooked. Hence its reputation as a versatile enhancer capable of combining with many other substances. Yet that same subtlety dampened its popularity: in modest doses, it is gentle, almost unremarkable, prompting some to describe it as an alertness booster rather than a classic psychedelic.
In the qualitative commentary of PIHKAL, 2C-D appears chameleonic: ranging from a barely perceptible lift in focus and a “desire to learn” to fully psychedelic experiences with rich visual enhancement when the dose is increased significantly. Shulgin also noted its rough edges—mild physical restlessness, an uneasy body load, and difficulty dialing in the right dose—alongside its brief duration of just a few hours. It remains a nuanced profile, far from uncritical praise.
Critical Reading and Harm Reduction
Beyond its historical intrigue, this material warrants careful perspective. A few key considerations:
- Testimony, not clinical science. Both the lucid dream accounts and the 2C-D reports reflect personal self-experimentation from the era when PIHKAL and TIHKAL were written. They are not clinical trials and do not establish medical safety or therapeutic efficacy.
- The “tofu” fallacy. The premise that a substance “adds little of its own” and pairs well with anything actively encourages poly-drug combinations, which compound unpredictability and health risks. A benign low dose offers zero guarantee of how it behaves at higher amounts or when mixed with other agents.
- Narrow margins and chemical uncertainty. With synthetic phenethylamines, the boundary between a threshold effect and an overwhelming experience can be remarkably small. Furthermore, unregulated markets rarely deliver what is on the label; adulteration and mix-ups between structurally similar analogs pose serious dangers.
- Legal status. The legal status of these compounds varies across jurisdictions and shifts over time; this article provides no guidance on sourcing or consumption.
Lucid dreaming, by contrast, serves as a reminder that some of the mind’s most extraordinary altered states require no exogenous chemistry at all. That may be the most grounded takeaway from a chapter that pivots seamlessly between an intimate nocturnal revelation and a bench chemist’s notebook.
